After Goldman Sachs and Nomura, economists warn of more cuts in FY22 GDP forecasts

Economists of other agencies like SBI and ICRA say that the impact of rising COVID cases and more localized lockdowns will have a significant impact on their GDP forecasts.

Arup Roychoudhury
April 15, 2021 / 03:20 PM IST

Migrant workers going back home due to lockdowns. [Image: Shutterstock]

The threat to gross domestic product (GDP) from the second pandemic surge looms large.

As India faces a massive rise in COVID-19 cases, and the possibility of more localized lockdowns becomes a reality leading to a possible drop in economic activity, analysts warn that GDP forecasts for 2021-22 could be revised downwards.

So far, Goldman Sachs and Nomura have cut their GDP forecast for the fiscal year which began April 1.

Goldman Sachs has cut its forecast to a 10.5 per cent growth from 10.9 percent earlier, saying that a record number of pandemic cases and a host of key states announcing stricter lockdowns of late, have fuelled serious growth concerns, leaving investors worried about the risks to macro and earnings recovery.

Nomura has gone for an even steeper cut. It now sees GDP growth for 2021-22 at 12.6 per cent, down from 13.5 percent earlier. “Daily new COVID cases under the second wave have now exceeded the first wave peak, and more states have joined the worst-affected state of Maharashtra in entering quasi- lockdown," Nomura said.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Economists of other agencies concur, saying that the impact of rising COVID cases and more localized lockdowns will have a significant impact on their GDP forecasts.

Soumya Kanti Ghosh, Chief Economic Advisor of State Bank of India, told Moneycontrol: “There is going to be a significant impact on GDP. It is difficult to identify the quantum of that impact right now. With more and more localized lockdowns, now that the spread is much more than last year, the impact on the economy will be more than what was earlier anticipated.”

India reported the highest single-day rise of 2,00,739 new coronavirus infections on April 15, pushing the total tally of cases to 1,40,74,564, while active cases surpassed the 14-lakh mark. The death toll increased to 1,73,123 with 1,038 daily new fatalities, the highest since October 18, 2020, the data showed.

Data over next few weeks crucial

“For April-June, we had earlier expected a GDP expansion of 27.5 per cent, boosted by the low base. With the surging cases and evolving restrictions, the pace of GDP growth in the ongoing quarter may be tempered to 20-25 per cent,” said Aditi Nayar, Chief Economist, ICRA Ltd.

Both Nayar and Ghosh said they will monitor high frequency data, including mobility index, industrial production, manufacturing sentiment, power consumption and toll collection data, over the next few weeks.

Ghosh said he is likely to revise his GDP forecasts for the year in May, depending on the spread of the second COVID ‘wave’, while Nayar said she will take a relook at her forecasts after the official GDP data for January-March quarter comes out on May 31.

Nayar added: “The extent to which restrictions are imposed across multiple states on manufacturing, as well as the availability of migrant labour will have a critical bearing on the supply disruptions that may emerge. With sentiment souring, there may be some loss of demand in H1 FY2022, especially in the contact-intensive sectors, and some shifting of demand from H1 to H2 FY2022.”

Meanwhile, global ratings agencies Fitch and Moody’s, though maintaining their forecasts for now, have said that the rise in cases poses a big downside risk.

latest gdp 1504_001

“The government's more accommodative fiscal stance may also mitigate some short-term growth pressures. However, inoculating India's large population in a fast and effective way will be important to avoid repeated disruptions," Fitch said last week, adding India's second wave of COVID-19 infections poses increased risks for fragile economic recovery and its banks.

Moody’s said earlier this week that the second wave and new restrictions imposed to contain the surge pose a credit-negative threat and risks weakening the country's economic recovery. "The second wave presents a risk to our growth forecast as the virus management measures will curb economic activity and could dampen market and consumer sentiment,” it explained.
Arup Roychoudhury
TAGS: #Covid-19 #Economy #GDP #lockdown
first published: Apr 15, 2021 02:22 pm